0001628280-22-031725.txt : 20221212 0001628280-22-031725.hdr.sgml : 20221212 20221212162214 ACCESSION NUMBER: 0001628280-22-031725 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221209 FILED AS OF DATE: 20221212 DATE AS OF CHANGE: 20221212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NEIL GARRY ARTHUR CENTRAL INDEX KEY: 0001586785 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 221457382 MAIL ADDRESS: STREET 1: 555 CALIFORNIA STREET STREET 2: SUITE 365 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: Cerecor Inc. DATE OF NAME CHANGE: 20111102 4 1 wf-form4_167088011975647.xml FORM 4 X0306 4 2022-12-09 0 0001534120 Avalo Therapeutics, Inc. AVTX 0001586785 NEIL GARRY ARTHUR C/O AVALO THERAPEUTICS 540 GAITHER ROAD, SUITE 400 ROCKVILLE MD 20850 1 1 0 0 CEO and Chairman of the Board Common Stock 2022-12-09 4 P 0 2083 4.42 A 9220 D These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan. /s/ Christopher Sullivan, by Power of Attorney 2022-12-12